Bookmark

Add to MyYahoo RSS

Orexigen Therapeutics News

News on Orexigen Therapeutics (Ticker: OREX) continually updated from thousands of sources around the net.

Wednesday Jul 16 | AmericanBankingNews.com

Orexigen Therapeutics Given "Neutral" Rating at Zacks

's stock had its "neutral" rating restated by Zacks in a research report issued on Wednesday.

Comment?

Related Topix: Biotech, Orexigen Therapeutics

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••